Poorer nations refuse millions of AstraZeneca COVID vaccines from COVAX: Document Ruchika Sharma17 April 2022 9:00 AM ISTCountries declined to receive nearly 35 million AstraZeneca doses, opting to replace them with vaccines manufactured by Johnson and Johnson, Pfizer...
Very small blood clot risk after first AstraZeneca COVID dose, suggests Study MD Bureau24 Feb 2022 9:00 AM ISTStudy found no risk of major arterial and venous thrombotic events in those aged 70 or above with either of the vaccines.
Health Bulletin 30/November/2021 Roshni Dhar30 Nov 2021 5:38 PM ISTHere are top Health stories of the dayCourt junks plea of 2 Accused in PGIMER MD seat scam, finds Prima Facie Case against 27In the latest development...
AstraZeneca gets CDSCO panel nod to conduct cancer drug Trastuzumab Deruxtecan study Medical Dialogues Team29 Nov 2021 6:21 PM ISTNew Delhi: In a significant development, major drug-maker AstraZeneca has got the go ahead from the Subject Expert Committee (SEC) functional under...
AstraZeneca begins to earn mild profit from Covid-19 vaccine Ruchika Sharma15 Nov 2021 3:37 PM ISTNew Delhi: AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the...
AstraZeneca Covid-19 vaccine shows 74 percent efficacy in US trial Ruchika Sharma2 Oct 2021 10:00 AM ISTChicago: AstraZeneca Plc's COVID-19 vaccine demonstrated 74% efficacy at preventing symptomatic disease, a figure that increased to 83.5% in people...
Serum Institute to invest Rs 501 crore in Oxford Biomedica Ruchika Sharma26 Sept 2021 9:30 AM ISTNew Delhi: Vaccine maker Serum Institute of India (SII) will invest 50 million pounds ($68 million) in Oxford Biomedica to help fund the development...
Withdraw marketing of Durvalumab for metastatic urothelial carcinoma: CDSCO panel tells AstraZeneca Medical Dialogues Team27 July 2021 5:43 PM ISTNew Delhi: In a major setback to AstraZeneca Pharma India Limited., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Restrict AstraZeneca COVID vaccine for people above 60: EMA official Ruchika Sharma14 Jun 2021 10:00 AM ISTNew Delhi: Countries should also avoid giving the Astrazeneca coronavirus vaccine to people over 60, the head of the EU drug regulator's Covid-19 task...
Abbott, AstraZeneca terminate agreement for diabetes drug Dapagliflozin in India Ruchika Sharma30 May 2021 10:15 AM ISTNew Delhi: Drug major AstraZeneca Pharma India on Friday said it has terminated its distribution agreements with Abbott Healthcare for type 2 diabetes...
Double dose of COVID vaccines effective against India variant, says English health officials Ruchika Sharma24 May 2021 9:30 AM ISTLondon: A double dose of COVID-19 vaccines is almost as effective against the fast-spreading variant of the coronavirus first identified in India as...
USFDA flags problems at factory making Johnson and Johnson COVID vaccine Ruchika Sharma24 April 2021 12:00 PM ISTNew Delhi: The Baltimore factory hired to help make Johnson & Johnson's Covid-19 vaccine was dirty, didn't follow proper manufacturing procedures...
